Pre-exposure prophylaxis (PrEP) use among females in the US has been underwhelming. We created a peer outreach and navigation PrEP intervention to boost uptake. To evaluate the intervention, 32 cisgender women and 3 transgender women participated in semi-structured qualitative interviews. To find the intervention's facilitators and obstacles, we took a theme approach. Interest in PrEP, the provision of health and social services, the intervention's focus on women, and peer outreach and navigation were all facilitators. Perceived HIV risk worries about adverse drug reactions or combinations, housing insecurity, travel difficulties, co-existing health issues, and caregiving obligations were barriers.
<h3>What is Pre-exposure Prophylaxis (PrEP)?</h3>
Pre-exposure prophylaxis (PrEP) is the administration of drugs to persons who have not yet been exposed to a disease-causing agent, typically a virus, in an effort to stop the spread of illness. The phrase usually refers to the use of antiviral medications as a strategy for HIV/AIDS prevention.
<h3>What is the best medication for HIV?</h3>
Antiretroviral therapy is the name given to HIV medication (ART). - There is no reliable treatment for HIV. But HIV can be managed with the right medical attention. - Within six months, the majority of people can control the infection. - The use of HIV medication does not shield against the spread of other STDs.
Learn more about Pre-exposure Prophylaxis (PrEP):
brainly.com/question/12683534
#SPJ4
